MBII News and Press, Marrone Bio Innovations Inc. From 02/11/20

DAVIS, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced the completion of a study, conducted in cooperation with UC-Davis Graduate School of Manageme...

Novel biofungicide effective on specialty crops for yield-robbing diseases DAVIS, Calif., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that its nove...

DAVIS, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Marrone Bio (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced a $13.0 million expansion of its existing accounts-receivable credit facility which now totals $20.0 million, a...

Cellect Biotechnology (NASDAQ: APOP ) +141%  on new patents . More news on: Cellect Biotechnology Ltd., Apellis Pharmaceuticals, Inc., Advaxis, Inc., Stocks on the move, Read more ...

DAVIS, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that two of its biofungicide products—Stargus ® and Regalia ® —have b...

DAVIS, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Marrone Bio (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced the results of new U.S. field trials of its next-generation nematicide/insecticide, which showed superior contr...

DAVIS, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that its 2019 field trial results for biology-based seed treatments in Europe demonstrate...

Marrone Bio Innovations ( MBII -1% ) announced that the company's founder Dr. Pamela Marrone will retire from her position as CEO. More news on: Marrone Bio Innovations, Inc., Read more ...

DAVIS, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that company founder Dr. Pamela Marrone will retire from her position as chief executive ...

Marrone Bio Innovations, Inc. (MBII) Q3 2019 Results Conference Call November 12, 2019 04:30 PM ET Company Participants Linda Moore - General Counsel Pam Marrone - CEO Jim Boyd - President and CFO Kevin Hammill - Chief Commercial Officer Conference Call Participants Samee...